Medicus Sciences Acquisition Corp.

Medicus Sciences Acquisition Corp. (Nasdaq: MSAC) is a blank-check company targeting the healthcare and life sciences sector, having completed its initial public offering in 2021. Sponsored by Medicus Sciences Sponsor LLC, the company was organized to identify and execute a business combination with an operating company in the medical, biotechnology, or life sciences space. MSAC filed a Form 10-Q with the Securities and Exchange Commission on May 12, 2022, under accession number 0001104659-22-059489, a routine quarterly disclosure reflecting the company's status during its search phase. For full filing history, sponsor profiles, deal timelines, and comparable SPAC analytics on MSAC, sign up for complete data access at SpacDesk.